×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
S40 : Toward the Better Timing and Necessary Measures to Initiate Pediatric Drug Development: For the Well-being of Pediatric Patients
Session Chair(s)
Kayoko Kikuchi
Translational Research Headquarters,Center for Translational Research
FUJITA HEALTH UNIVERSITY, Japan
Speaker(s)
Ayumu Arakawa
National Cancer Center Hospital, Japan
Head of physicians
Katsuaki Ura
Ministry of Health, Labour and Welfare (MHLW), Japan
Deputy Director, Office of International Regulatory Affairs
Mariko Kozai, MPharm
Pfizer R&D Japan, Japan
Regulatory Affairs
Hidefumi Nakamura, MD, PhD
National Center for Child Health and Development, Japan
Director for Clinical R&D,
Kana Harada
Toho University Omori Medical Center, Japan
Child Life Specialist
Have an account?